Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics.

@article{Schreiner2014PaliperidoneEI,
  title={Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics.},
  author={Andreas Schreiner and Marjolein Lahaye and Joseph Peuskens and Dieter Naber and Nesrin Dilbaz and Bruno Millet and Manuel A Franco and Elmārs Rancāns and Jacek Turczyński and Enrico Smeraldi and Elsa Lara and Nikolaj G. Neznanov},
  journal={Expert opinion on pharmacotherapy},
  year={2014},
  volume={15 5},
  pages={593-603}
}
OBJECTIVE This study explores relevant outcomes with flexibly dosed paliperidone extended-release (ER) in a real-world design. RESEARCH DESIGN AND METHODS Patients were recruited from 23 countries. Adults with non-acute schizophrenia (n = 1812), previously unsuccessfully treated with other oral antipsychotics, were transitioned to paliperidone ER and prospectively treated for 6 months. MAIN OUTCOME MEASURES Primary efficacy outcome for patients switching for the main reason of lack of… CONTINUE READING

From This Paper

Topics from this paper.
6 Citations
0 References
Similar Papers

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…